Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Inspire Medical Systems Community
NYSE:INSP Community
2
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Inspire Medical Systems
Popular
Undervalued
Overvalued
Community Investing Ideas
Inspire Medical Systems
AN
AnalystHighTarget
Consensus Narrative from 16 Analysts
Simplified Implant Procedure Will Satisfy Aging Global OSA Demand
Key Takeaways Streamlined implant procedures and enhanced patient access are driving higher adoption, fueling sustained revenue and long-term demand for sleep apnea therapy. Expanding globally with new market entries and reimbursement pathways boosts operating leverage and supports multi-year growth prospects.
View narrative
US$270.00
FV
41.1% undervalued
intrinsic discount
19.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Inspire Medical Systems
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
New Leadership And Reimbursement Expansion Will Drive Therapy Adoption
Key Takeaways Strategic organizational changes and expanded reimbursement policies are expected to boost revenue growth by enhancing provider capacity and patient access. The launch of the Inspire V neurostimulator and SleepSync system aims to increase adoption, reduce operational complexities, and improve net margins.
View narrative
US$220.64
FV
27.9% undervalued
intrinsic discount
17.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
INSP
INSP
Inspire Medical Systems
Your Fair Value
US$
Current Price
US$159.06
0.6% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-57m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.6b
Earnings US$104.2m
Advanced
Set Fair Value